Siping Road 1500, 
Shanghai, CN 

Overview

Shanlang Lin practices practicing medicine in Shanghai, China.

Their clinical expertise encompasses COVID-19 and Severe Acute Respiratory Syndrome (SARS).

They are actively involved in clinical research, co-authoring 10 peer reviewed articles.

Locations

Siping Road 1500, Shanghai, 200092, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


Frequently Asked Questions about Shanlang Lin

Is Shanlang Lin a top-rated expert for COVID-19?

MediFind is an objective health platform that identifies experts based on real-world data. Shanlang Lin is classified as an Experienced expert for COVID-19, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Shanlang Lin participate in research or clinical trials?

Yes. Shanlang Lin has published 10 articles and abstracts on conditions like COVID-19. You can view a list of Shanlang Lin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Lin's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile